<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 31, 2000
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________________ to _______________________
Commission File No. 0-11488
Penford Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Washington 91-1221360
--------------------------------------------------------------------------------
(State of Incorporation) (I.R.S. Employer
Identification No.)
777-108th Avenue N.E., Suite 2390, Bellevue, WA 98004-5193
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (425) 462-6000
Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of July 5, 2000.
<TABLE>
<CAPTION>
Class Outstanding
----- -----------
<S> <C>
Common stock, par value $1.00 7,403,924
</TABLE>
<PAGE> 2
PENFORD CORPORATION AND SUBSIDIARIES
INDEX
<TABLE>
<CAPTION>
Page No.
--------
<S> <C>
PART I - FINANCIAL INFORMATION
Item 1 - Financial Statements
Condensed Consolidated Balance Sheets
May 31, 2000 and August 31, 1999 3
Condensed Consolidated Statements of Income
Three and Nine Months Ended May 31, 2000
and May 31, 1999 4
Condensed Consolidated Statements of Cash Flow
Nine Months Ended May 31, 2000 and
May 31, 1999 5
Notes to Condensed Consolidated Financial Statements 6-7
Item 2 - Management's Discussion and Analysis of
Financial Condition and Results of Operations 8-10
Item 3 - Quantitative and Qualitative Disclosures
About Market Risk 10
PART II - OTHER INFORMATION
Item 1 - Legal Proceedings 11
Item 2 - Changes in Securities 11
Item 3 - Defaults Upon Senior Securities 11
Item 4 - Submission of Matters to a Vote of Security Holders 11
Item 5 - Other Information 11
Item 6 - Exhibits and Reports on Form 8-K 11-13
SIGNATURES 14
</TABLE>
2
<PAGE> 3
PART I - FINANCIAL INFORMATION
Item 1 Financial Statements
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
<TABLE>
<CAPTION>
May 31, 2000 August 31, 1999
------------ ---------------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 447 $ 15
Trade accounts receivable 17,758 18,418
Inventories:
Raw materials and other 3,633 3,423
Work in progress 415 438
Finished goods 7,601 6,260
--------- ---------
11,649 10,121
Prepaid expenses and other 6,796 4,384
--------- ---------
Total current assets 36,650 32,938
Net property, plant and equipment 114,903 111,072
Deferred income taxes 12,925 13,849
Restricted cash value of life insurance 12,180 11,896
Other assets 3,206 3,378
--------- ---------
Total assets $ 179,864 $ 173,133
========= =========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 11,256 $ 9,655
Accrued liabilities 11,751 9,185
Current portion of long-term debt 2,857 3,277
--------- ---------
Total current liabilities 25,864 22,117
Long-term debt 50,729 53,101
Other postretirement benefits 10,746 10,572
Deferred income taxes 20,402 21,769
Other liabilities 6,449 5,876
Shareholders' equity:
Common stock 9,341 9,267
Additional paid-in capital 22,208 21,459
Retained earnings 66,310 59,370
Treasury stock (32,185) (30,327)
Note receivable from Savings and
Stock Ownership Plan
-- (71)
--------- ---------
Total shareholders' equity 65,674 59,698
--------- ---------
Total liabilities and shareholders' equity $ 179,864 $ 173,133
========= =========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
3
<PAGE> 4
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in thousands except per share data)
<TABLE>
<CAPTION>
Three Months Ended May 31 Nine Months Ended May 31
----------------------------- -----------------------------
2000 1999 2000 1999
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Sales $ 39,744 $ 39,226 $ 118,629 $ 115,146
Cost of sales 28,633 29,008 85,248 85,408
----------- ----------- ----------- -----------
Gross margin 11,111 10,218 33,381 29,738
Operating expenses 4,243 4,811 13,313 13,696
Research and development 1,365 1,423 4,031 3,846
Restructure costs -- 1,559 -- 1,559
----------- ----------- ----------- -----------
Income from operations 5,503 2,425 16,037 10,637
Interest expense (1,051) (1,343) (3,532) (4,087)
----------- ----------- ----------- -----------
Income before taxes 4,452 1,082 12,505 6,550
Income taxes 1,558 379 4,377 2,293
----------- ----------- ----------- -----------
Net income $ 2,894 $ 703 $ 8,128 $ 4,257
=========== =========== =========== ===========
Weighted average common shares and
equivalents outstanding 7,795,053 7,701,498 7,758,400 7,767,554
Earnings per common share:
Net income
Basic $ 0.39 $ 0.09 $ 1.10 $ 0.58
=========== =========== =========== ===========
Diluted $ 0.37 $ 0.09 $ 1.05 $ 0.55
=========== =========== =========== ===========
Dividends declared per common share $ 0.06 $ 0.05 $ 0.16 $ 0.15
=========== =========== =========== ===========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
4
<PAGE> 5
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Dollars in thousands)
<TABLE>
<CAPTION>
Nine Months Ended May 31
------------------------
2000 1999
-------- ---------
<S> <C> <C>
Operating Activities:
Net income $ 8,128 $ 4,257
Adjustments to reconcile net income
to net cash from operations:
Depreciation 10,168 9,250
Deferred income taxes (444) (260)
Change in operating assets and liabilities:
Trade receivables 660 2,168
Inventories (1,528) 4,494
Accounts payable, prepaids and other 2,113 4,610
Net cash used in discontinued operations -- (1,133)
-------- --------
Net cash from operating activities 19,097 23,386
Investing Activities:
Additions to property, plant and equipment, net (13,938) (13,064)
Other 575 475
-------- --------
Net cash used by investing activities (13,363) (12,589)
Financing Activities:
Proceeds from unsecured line of credit 44,177 26,320
Payments on unsecured line of credit (43,692) (30,671)
Proceeds of long-term debt -- 10,000
Payments on long-term debt (3,277) (17,487)
Exercise of stock options 466 645
Purchase of treasury stock (1,858) (919)
Payment of dividends (1,118) (1,103)
-------- --------
Net cash used by financing activities (5,302) (13,215)
-------- --------
Net increase (decrease) in cash and equivalents 432 (2,418)
Cash and cash equivalents at
beginning of period 15 3,200
-------- --------
Cash and cash equivalents at
end of period $ 447 $ 782
======== ========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
5
<PAGE> 6
PENFORD CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BUSINESS
Penford Corporation ("Penford" or the "Company") develops, manufactures
and markets specialty carbohydrate-based ingredient systems for various
applications, including papermaking, textiles and food products. The
Company utilizes its expertise in carbohydrate chemistry to develop
functional ingredient formulations using starch as a base for
value-added applications in the markets its products are sold.
The Company has extensive research and development capabilities, which
are used in understanding the complex chemistry of carbohydrate-based
materials and their application in a variety of commercial markets. In
addition, the Company has specialty processing capabilities for a
variety of modified starches, all of which have similar production
methods. Penford's core carbohydrate-based specialty starches possess
excellent binding and film-forming attributes in both industrial and
food applications.
2. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions
to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not
include all of the information and footnotes required by generally
accepted accounting principles for complete financial statements. In the
opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation for the interim
periods presented have been included. The preparation of financial
statements in conformity with generally accepted accounting principles
requires management to make estimates and assumptions that affect the
amounts reported in the financial statements and accompanying notes.
Actual results could differ from those estimates. Operating results for
the three and nine month periods ended May 31, 2000 are not necessarily
indicative of the results that may be expected for the year ending
August 31, 2000. For further information, refer to the consolidated
financial statements and footnotes thereto included in Penford
Corporation's annual report on Form 10-K for the fiscal year ended
August 31, 1999.
Certain prior year amounts have been reclassified to conform with
current year presentation, which had no effect on previously reported
net income.
6
<PAGE> 7
3. EARNINGS PER COMMON SHARE
The following table presents the computation of basic and diluted
earnings per share under SFAS No. 128 (Dollars in thousands except per
share data):
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
May 31 May 31
-------------------------- --------------------------
2000 1999 2000 1999
---------- ---------- ---------- ----------
<S> <C> <C> <C> <C>
Net income $ 2,894 $ 703 $ 8,128 $ 4,257
========== ========== ========== ==========
Weighted average common
shares outstanding 7,417,229 7,416,605 7,419,943 7,389,852
Net effect of dilutive
stock options 377,824 284,893 338,457 377,702
---------- ---------- ---------- ----------
Weighted average common shares
outstanding assuming dilution 7,795,053 7,701,498 7,758,400 7,767,594
========== ========== ========== ==========
Earnings per common share:
Net income
Basic $ 0.39 $ 0.09 $ 1.10 $ 0.58
========== ========== ========== ==========
Diluted $ 0.37 $ 0.09 $ 1.05 $ 0.55
========== ========== ========== ==========
</TABLE>
Basic earnings per share reflects only the weighted average common
shares outstanding. Diluted earnings per share reflects weighted average
common shares outstanding and the effect of any dilutive common stock
equivalent shares.
7
<PAGE> 8
Item 2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
RESULTS OF OPERATIONS
Consolidated sales increased to $39.7 million from $39.2 million, or 1.3%, in
the third quarter of fiscal 2000 versus the same prior year period. Sales for
the first nine months of fiscal 2000 increased to $118.6 million from $115.1
million, or 3.0%, compared to the same prior year period. Sales growth for the
quarter and nine-month period is attributed to higher company-wide sales volumes
of specialty starches. Lower corn costs, a key pricing component, and pricing
pressures on certain paper ingredient products continued to dampen overall sales
growth.
Industrial sales volumes of specialty products increased approximately 10% in
the third quarter and approximately 9% in the first nine months of fiscal 2000
on solid operating performance for industrial ingredients, including paper and
textiles.
Sales volumes of specialty food starches in the third quarter and first nine
months of fiscal 2000 increased 34% and 27%, respectively, over the same periods
in the prior year. The continued strong demand for food-grade, starch-based
systems for food industry customers resulted in the overall increase in
consolidated sales.
Gross margin improved to $11.1 million, or 28.0%, in the third quarter, from
$10.2 million, or 26.1%, in the corresponding prior year period. The gross
margin improvement is the result of higher sales volume and manufacturing
efficiency gains across all of the Company's product lines. Cost savings
achieved in manufacturing and raw material purchasing for specialty starches for
papermaking applications more than offset the related pricing pressures and
slightly higher energy costs. Gross margin for the nine months ended May 31,
2000 increased to $33.4 million, or 28.1%, from $29.7 million, or 25.8%, for the
same nine-month period in the prior year. The year-to-date improvement is also
attributed to the volume increases, efficiency gains and cost savings.
Operating expenses in the third quarter of $4.2 million were $568,000 lower
compared to the same quarter in the prior year. For the nine months ended May
31, 2000, operating expenses decreased to $13.3 million from $13.7 million. The
decreases resulted primarily from lower corporate costs and the effect of the
prior year's workforce reduction program.
Restructuring costs totaling $1.6 million were charged to continuing operations
in the third quarter a year ago in connection with the workforce reduction
program.
Research and development expenses in the third quarter of $1.4 million were
consistent with the same quarter in the prior year. For the nine months ended
May 31, 2000, research and development expenses increased 5% compared to the
prior year, primarily due to commercialization efforts and alliance activities
in specialty ingredient systems.
Net interest expense for the third quarter and first nine months of fiscal 2000
was $1.1 million and $3.5 million, respectively, compared to $1.3 million and
$4.1 million,
8
<PAGE> 9
respectively, in the corresponding periods a year ago. The decreases reflect
lower outstanding debt balances.
The effective tax rate for the third quarter and first nine months of fiscal
2000 was 35%, the same as in the corresponding periods a year ago. The effective
rate for the full fiscal year is expected to be similar.
Net income for the third quarter ended May 31, 2000 was $2.9 million, or $0.37
per share, compared to net income of $703,000, or $0.09 per share in the
corresponding prior year period. Net income for the nine months ended May 31,
2000 was $8.1 million, or $1.05 per share, compared to $4.3 million, or $0.55
per share, for the same period in the prior year. The quarter and nine-month
prior year periods include the $1.6 million restructuring charge ($1.0 million
after tax) noted above. All per share amounts above assume dilution.
LIQUIDITY AND CAPITAL RESOURCES
At May 31, 2000, Penford had working capital of $10.8 million, an unsecured
credit agreement of $75.0 million under which there was $34.0 million
outstanding, and several uncommitted lines of credit aggregating $10.0 million
under which there was $1.0 million outstanding. The Company used operating cash
flow through the first nine months of fiscal 2000 primarily to invest in capital
expenditures of $13.9 million and to fund financing activities of $5.3 million,
including principal debt repayments of $2.8 million.
Cash flow from operations for the nine months ended May 31, 2000 was $19.1
million compared to $23.4 million in the corresponding period of the prior year.
The decrease in operating cash flow compared to the prior year is due to
fluctuations in the components of working capital, primarily due to efforts in
the prior year to reduce inventory, offset by higher net income in the current
fiscal year.
The Company began paying a quarterly cash dividend of $0.05 per share in 1992
and has continued to pay quarterly dividends ever since. On April 3, 2000, the
Board of Directors approved an increase in the quarterly cash dividend to $0.06
per share.
In November of 1998, the Board of Directors authorized a stock repurchase
program for the purchase of up to 500,000 shares of the outstanding stock of the
company. The Company repurchased 112,800 shares of its common stock in the first
nine months of fiscal 2000 for approximately $1.9 million. From inception of the
program through May 31, 2000, the Company has repurchased 253,000 shares of its
common stock for $3.8 million.
Net additions to property, plant and equipment during the third quarter of $5.4
million were primarily for various improvements at the Company's industrial
facility in Cedar Rapids, Iowa and equipment additions and improvements at the
Company's food-grade manufacturing facilities.
9
<PAGE> 10
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements concerning the anticipated
performance and results of the Company. There are a variety of factors which
could cause actual events or results to differ materially from those projected
in the forward-looking statements, including, without limitation, competition;
the possibility of interruption of business activities due to equipment
problems, accidents, strikes, weather or other factors; product development
risk; changes in raw material prices and/or energy costs; interest rate
volatility; changes in general economic conditions or developments with respect
to specific industries or customers affecting demand for the Company's products
including unfavorable shifts in product mix; unanticipated costs, expenses or
third party claims; the risk that results may be affected by construction
delays, cost overruns, technical difficulties, nonperformance by contractors or
changes in capital improvement project requirements or specifications; or other
unforeseen developments in the industries in which the Company operates.
Accordingly, there can be no assurance that future activities or results will be
as anticipated.
Forward-looking statements are based on the estimates and opinions of management
on the date the statements are made. The Company assumes no obligation to update
any forward-looking statements if circumstances or management's estimates or
opinions should change.
Additional information which could affect the Company's financial results is
included in the Company's 1999 Annual Report to Shareholders and its Form 10-K
for the fiscal year ended August 31, 1999 on file with the Securities and
Exchange Commission.
Item 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
MARKET RISK SENSITIVE INSTRUMENTS AND POSITIONS
The market risk associated with the Company's market risk sensitive instruments
is the potential loss from adverse changes in interest rates and commodities
prices.
The Company is unaware of any material changes to the market risk disclosures
referred to in the Company's Report on Form 10-K for the year ended August 31,
1999.
10
<PAGE> 11
PART II - OTHER INFORMATION
Item 1 Legal Proceedings
A complaint was filed in late November 1999 against Penford in the
United States District Court for the District of Idaho, alleging various
violations of the federal Clean Air Act, as well as claims for trespass
and nuisance by alleged emissions from Penford's Idaho Falls starch
processing plant. The subject of the complaint involves alleged
excessive starch emissions that occurred in 1996 and 1997, which were
previously disclosed by the Company, and certain other alleged
violations relating to the plant. The complaint sought civil penalties,
together with private damages. By agreement of the parties, the Federal
Clean Air Act claims have been dismissed with prejudice. Non-binding
mediation for the remaining trespass and nuisance claims is tentatively
scheduled for late August.
Item 2 Changes in Securities Not applicable
Item 3 Defaults Upon Senior Securities Not applicable
Item 4 Submission of Matters to a Vote of Security Holders Not applicable
Item 5 Other Information Not applicable
Item 6 Exhibits and Reports on Form 8-K.
(a) Exhibits:
(3.1) Restated Articles of Incorporation of Registrant (filed
as an Exhibit to Registrant's Form 10-K for fiscal year
ended August 31, 1995)
(3.2) Articles of Amendment to Restated Articles of
Incorporation of Registrant (filed as an exhibit to
Registrant's Form 10-K for fiscal year ended August 31,
1997)
(3.3) Bylaws of Registrant as amended and restated as of
October 20, 1997 (filed as an exhibit to Registrant's
Form 10-K for fiscal year ended August 31, 1997)
(4.1) Amended and Restated Rights Agreement dated as of April
30, 1997 (filed as an Exhibit to Registrant's Amendment
to Registration Statement on Form 8-A/A dated May 5,
1997)
(10.1) Senior Note Agreement among Penford Corporation as
Borrower and Mutual of Omaha and Affiliates as lenders,
dated November 1, 1992 (filed as an Exhibit to
Registrant's Form 10-Q for the quarter ended February
28, 1993)
11
<PAGE> 12
(10.2) Penford Corporation Supplemental Executive Retirement
Plan, dated March 19, 1990 (filed as an Exhibit to
Registrant's Form 10-K for the fiscal year ended
August 31, 1991)
(10.3) Penford Corporation Supplemental Survivor Benefit Plan,
dated January 15, 1991 (filed as an Exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1991)
(10.4) Penford Corporation Deferred Compensation Plan, dated
January 15, 1991 (filed as an Exhibit to Registrant's
Form 10-K for the fiscal year ended August 31, 1991)
(10.5) Change of Control Agreements between Penford Corporation
and Messrs. Cook and Horn (a representative copy of
these agreements is filed as an exhibit to Registrant's
Form 10-K for the fiscal year ended August 31, 1995)
(10.6) Penford Corporation 1993 Non-Employee Director
Restricted Stock Plan (filed as an Exhibit to
Registrant's Form 10-Q for the quarter ended November
30, 1993)
(10.7) Senior Note Agreement dated as of October 1, 1994 among
Penford Corporation, Principal Mutual Life Insurance
Company and TMG Life Insurance Company (filed as an
Exhibit to Registrant's Form 10-Q for the quarter ended
February 28, 1995)
(10.8) Penford Corporation 1994 Stock Option Plan as amended
and restated as of January 21, 1997 (filed on Form S-8
dated March 17, 1997)
(10.9) Penford Corporation Stock Option Plan for Non-Employee
Directors (filed as an exhibit to the Registrant's Form
10-Q for the quarter ended May 31, 1996)
(10.10) Separation Agreement dated as of July 31, 1998 between
Registrant and Penwest Pharmaceuticals Co. (filed as an
exhibit to Registrant's Form 8-K dated August 31, 1998)
(10.11) Services Agreement dated as of July 31, 1998 between
Registrant and Penwest Pharmaceuticals Co. (filed as an
exhibit to Registrant's Form 8-K dated August 31, 1998)
(10.12) Employee Benefits Agreement dated as of July 31, 1998
between Registrant and Penwest Pharmaceuticals Co.
(filed as an exhibit to Registrant's Form 8-K dated
August 31, 1998)
(10.13) Tax Allocation Agreement dated as of July 31, 1998
between Registrant and Penwest Pharmaceuticals Co.
(filed as an exhibit to Registrant's Form 8-K dated
August 31, 1998)
(10.14) Excipient Supply Agreement dated as of July 31, 1998
between Registrant and Penwest Pharmaceuticals Co.
(filed as an exhibit to Registrant's Form 8-K dated
August 31, 1998)
(10.15) Restatement and Exchange Agreement amending the Senior
Note Agreement among Penford Corporation as Borrower and
Mutual of Omaha and Affiliates as lenders, dated as of
August 1, 1998 (filed as an exhibit to Registrant's Form
10-K for the fiscal year ended August 31, 1998)
12
<PAGE> 13
(10.16) Co., a wholly-owned subsidiary of Registrant, of the
Restatement and Exchange Agreement among Registrant and
Mutual of Omaha and Affiliates (filed as an exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1998)
(10.17) Intercreditor Agreement dated as of August 1, 1998 among
the parties to the Credit Agreement dated July 2, 1998
and the parties to the Senior Note Agreements dated as
of August 1, 1998 (filed as an exhibit to Registrant's
Form 10-K for the fiscal year ended August 31, 1998)
(10.18) Restatement and Exchange Agreement amending the Senior
Note Agreement among Penford Corporation as Borrower,
and Principal Mutual Life Insurance Company and TMG Life
Insurance Company as lenders, dated as of August 1, 1998
(filed as an exhibit to Registrant's Form 10-K for the
fiscal year ended August 31, 1998)
(10.19) Guaranty Agreement dated as of August 1, 1998 by Penford
Products Co., a wholly-owned subsidiary of Registrant,
of the Restatement and Exchange Agreement among
Registrant, Principal Mutual Life Insurance Company, and
TMG Life Insurance Company (filed as an exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1998)
(10.20) Credit Agreement dated as of July 2, 1998 among Penford
Corporation and Penford Products Co. as borrowers, and
certain commercial lending institutions as the lenders,
and The Bank of Nova Scotia, as agent for the lenders
(filed as an exhibit to Registrant's Form 10-K for the
fiscal year ended August 31, 1998)
27 Financial Data Schedule
(b) There were no filings on Form 8-K in the quarter ended May 31,
2000.
13
<PAGE> 14
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Penford Corporation
-----------------------------------
(Registrant)
July 12, 2000 /s/ Jeffrey T. Cook
------------- -----------------------------------
Date Jeffrey T. Cook
President and
Chief Executive Officer (Principal
Executive Officer)
July 12, 2000 /s/ Keith T. Fujinaga
------------- -----------------------------------
Date Keith T. Fujinaga
Corporate Director of Finance
(Chief Accounting Officer)
14
